Polyvascular disease is the presence of atherosclerosis in more than one arterial bed. While it is not a new phenomenon, polyvascular disease has been brought to the forefront in recent years through the expansion of clinical and research endeavors that include non coronary atherosclerosis, specifically lower extremity peripheral artery disease and cerebrovascular disease. The relevance of polyvascular disease is centered on its associated heightened risk for cardiovascular death, myocardial infarction and ischemic stroke.
Faisal Hasan, MD, FACC, FSCAI, is the Clinical Division Chief of Cardiology at RUSH University Medical Center and the Co-Director of the Cardiovascular Service Line at RUSH. Dr. Hasan is also an associate Professor in the Department of Internal Medicine, Division of Cardiology, at Rush Medical College whose recent work has focused on investigating outcomes in patients who present with myocardial infarction and have coexisting polyvascular disease.
“[In treating polyvascular disease], the patient is at the center of the care management team and all care providers, regardless of their subspecialty, come together and unify to treat these complex patients. We have noticed that this kind of collaborative approach leads to improved coordination of care leading to better patient outcomes.”
CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/485203